Mengjun Wang, MD, MS

Dr. Mengjun Wang has 10+ years of experiences in in-vivo efficacy/safety studies of cardiovascular devices/pharmaceuticals. Prior to joining the 3DT Holdings, LLC, he worked at the Henry Ford Heart & Vascular Institute, MI for 12 years. His work fully focused on understanding the pathophysiology of heart failure, and the development and testing of novel therapeutic modalities for the treatment and prevention of heart failure and other cardiovascular diseases. He has extensive hands-on experiences in pre-clinical cardiovascular device studies with large animals and strong expertise in performing cardiovascular interventions/surgery. Dr. Wang obtained his MD and MS degrees from Hebei Medical University and Peking University in China and was a highly trained surgeon before moving to the USA. He received research training at Peking University, Creighton University and University of North Carolina at Chapel Hill. He also earned a MS degree in the Medical Informatics from the University of Nebraska at Omaha.